|
Report ID
|
125088 |
|
Drug Identification Number
|
02377225 |
|
Brand name
|
MOZOBIL |
|
Common or Proper name
|
Mozobil |
|
Company Name
|
SANOFI-AVENTIS CANADA INC |
|
Market Status
|
MARKETED |
|
Active Ingredient(s)
|
PLERIXAFOR |
|
Strength(s)
|
20MG |
|
Dosage form(s)
|
SOLUTION |
|
Route of administration
|
SUBCUTANEOUS
SUBCUTANEOUS |
|
Packaging size
|
1 x 2.0ml |
|
ATC code
|
L03AX |
|
ATC description
|
IMMUNOSTIMULANTS |
|
Reason for shortage
|
Other (Please describe in comments) |
|
Anticipated start date
|
2020-12-04 |
|
Actual start date
|
|
|
Estimated end date
|
Unknown |
|
Actual end date
|
2020-11-25 |
|
Shortage status
|
Avoided shortage |
|
Updated date
|
2020-11-25 |
|
Company comments
|
production/ supply delay - Considering the exceptional circumstances, the remaining stock will be distributed on allocation with a limit of 2 vials per order. Pharmacies are invited to communicate with their preferred distributor to obtain more information on product availability. |
|
Health Canada comments
|
|
|
Tier 3 Status
|
No |
| Company contact information |
email: [email protected]
Telephone: 1-800-265-7927 |
